LMS vs Leiomyoma — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Intravenous piperacillin-tazobactam monotherapy without routine aminoglycoside addition
Option C is correct: NICE recommends immediate piperacillin-tazobactam monotherapy unless patient-specific or local microbiology dictates otherwise. Option A uses an aminoglycoside alone. Option D adds two agents routinely despite no specific indication. Option B is unsafe in a hypotensive high-risk presentation, and option E is inadequate oral-spectrum management for neutropenic sepsis.
Reference: NICE CG151: neutropenic sepsis. https://www.nice.org.uk/guidance/CG151/chapter/key-priorities-for-implementation